Laboratory of Cell Biology, Ariel University, Ariel, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; Department of Obstetrics & Gynecology, E. Wolfson Medical Center, Holon, Israel.
J Steroid Biochem Mol Biol. 2018 Oct;183:137-141. doi: 10.1016/j.jsbmb.2018.06.007. Epub 2018 Jun 6.
Pseudohypoaldosteronism type 1 (PHA) is a syndrome of unresponsiveness to aldosterone. The severe form of this disease results from mutations in the genes that encode for the epithelial sodium channel subunits, SCNN1A, SCNN1B, and SCNN1G. A PHA patient under our care failed to conceive after many years and IVF trials. Our earlier studies had shown that ENaC is expressed in the female reproductive tract. We hypothesized that a defective ENaC expression may be responsible for the infertility of the patient. To test this hypothesis we examined ENaC expression in endometrial Pipelle biopsy samples from three healthy women and the PHA patient with an Arg508X mutation in the SCNN1A gene. The formalin fixed samples were reacted with anti-ENaCA (alpha subunit) antisera, followed by secondary antibodies to visualize ENaC expression by immunofluorescence. Confocal microscopy imaging of the samples showed strong ENaC immunofluorescence along the luminal border (apical membrane) of the epithelial cells in Pipelle samples from healthy women. In contrast, none of the samples from the PHA patient showed ENaC immunofluorescence. The Arg508X mutation interrupts the transport of ENaC subunits to the cell surface, yet it would not be expected to disrupt ENaC localization in the cytoplasm. In contrast to endometrium where ENaC is localized in the apical membrane of the epithelial cells, in keratinocytes ENaC is expressed in cytoplasmic pools. Therefore, we examined ENaC immunofluorescence in plucked hair follicles. As expected, ENaC immunofluorescence was detected in the cytoplasm of keratinocytes of both normal and PHA samples. Our results support the hypothesis that lack of expression of ENaC on the endometrial surface may be responsible for the infertility of the PHA patient.
假性醛固酮减少症 1 型(PHA1)是一种对醛固酮无反应的综合征。这种疾病的严重形式是由于编码上皮钠通道亚单位 SCNN1A、SCNN1B 和 SCNN1G 的基因突变引起的。我们治疗的一位 PHA 患者在多次试管婴儿试验后未能怀孕。我们之前的研究表明 ENaC 在上皮细胞中的表达。我们假设 ENaC 表达缺陷可能是导致患者不孕的原因。为了验证这一假设,我们检查了来自三名健康女性和携带 SCNN1A 基因 Arg508X 突变的 PHA 患者的子宫内膜 Pipelle 活检样本中的 ENaC 表达。福尔马林固定的样本用抗 ENaCA(α亚基)抗血清反应,然后用二级抗体通过免疫荧光检测 ENaC 表达。对样本的共聚焦显微镜成像显示,来自健康女性的 Pipelle 样本中,上皮细胞的腔侧(顶膜)有强烈的 ENaC 免疫荧光。相比之下,PHA 患者的样本均未显示 ENaC 免疫荧光。Arg508X 突变中断了 ENaC 亚基向细胞表面的转运,但不应破坏 ENaC 在细胞质中的定位。与 ENaC 定位于上皮细胞顶膜的子宫内膜不同,在角质形成细胞中,ENaC 表达在细胞质池。因此,我们检查了拔毛的毛囊中的 ENaC 免疫荧光。不出所料,正常和 PHA 样本中的角质形成细胞的细胞质中均检测到 ENaC 免疫荧光。我们的结果支持这样的假设,即子宫内膜表面 ENaC 表达缺失可能是 PHA 患者不孕的原因。